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Abstract: The aims of the current study were to determine the half-lethal concentration of 
ochratoxin  A  (OTA)  as  well  as  the  levels  of  lactate  dehydrogenase  release  and  DNA 
fragmentation induced by OTA in primary porcine fibroblasts, and to examine the role of 
-tocopherol  in  counteracting  its  toxicity.  Cells  showed  a  dose-,  time-  and  
origin-dependent (ear vs. embryo) sensitivity to ochratoxin A. Pre-incubation for 3 h with  
1  nM  -tocopherol  significantly  (P  <  0.01)  reduced  OTA  cytotoxicity,  lactate 
dehydrogenase  release  and  DNA  damage  in  both  fibroblast  cultures.  These  findings 
indicate  that  -tocopherol  supplementation  may  counteract  short-term  OTA  toxicity, 
supporting its defensive role in the cell membrane. 
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Abbreviations:  LC50—half-lethal  concentration;  LDH—lactate  dehydrogenase;  
MTT—3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide;  OTA—ochratoxin 
A; TUNEL—Terminal deoxynucleotidyl transferase dUTP nick end labeling 
 
1. Introduction 
Ochratoxin A (OTA) is a mycotoxin produced by Aspergillus and Penicillum species. It occurs in 
several agricultural products and causes diseases both in humans and animals [1]. OTA has been 
implicated in renal and hepatic toxicity, neurotoxicity, teratogenicity, and immunotoxicity [2], and it is 
considered by the International Agency for Research on Cancer as possibly carcinogenic (group 2B) to 
humans [3], making consistent exposure to OTA a cause of serious concern. 
The scientific panel on contaminants in the food chain of the European Food Safety Authority 
released an opinion related to OTA in food [4], in which it summarized the major information on OTA 
related to human health but also indicated the susceptibility of pigs and other animals to OTA. In 
porcine species, OTA is responsible for acute, subchronic and chronic intoxications, and the effects, 
correlated with the latter two, are of major concern for financial losses in the agriculture and food 
industry [5]. The main clinical patterns associated with OTA intoxication in swine are impaired renal 
function, depression, anorexia, decreased weight gain and productivity [6]. 
At  the  cellular  level,  OTA  toxicity  involves  various  mechanisms  of  action:  lipid  peroxidation, 
disruption of calcium homeostasis, inhibition of protein synthesis, mitochondrial respiration, and DNA 
damage [7]. The toxicological effects of OTA depend on the duration and concentration of exposure 
[5]. OTA can act in different ways: it can express its toxicity directly or by indirect mechanisms, such 
as  by  inducing  cytotoxicity,  oxidative  cell  damage  and  increased  cell  injury  [8].  Previous  reports  
[2,5–11] indicate that the OTA toxicity and DNA damage, measured in vivo and in vitro, are most 
likely attributable not only to cellular oxidative damage mediated by lipid peroxidation, but also to 
direct  genotoxic  effect.  However,  the  molecular  mechanism  involved  in  the  apoptotic  or 
antiproliferative effects of OTA is still unclear. In particular, O’Brien and Dietrich [5], in their review 
on OTA, highlighted its questionable role as a pro-apoptotic or pro-cytotoxic agent. Considering that 
induction of cell death is a process involving many factors, such as substance, dose/time exposure and 
the cellular in vitro models investigated, OTA could be responsible for an apoptotic or a necrotic 
process. Understanding the molecular mechanism of action of OTA is essential  for improving the 
toxicity-reducing countermeasures applied. 
-Tocopherol  is  a  member of the vitamin  E compound group  that  has  several  biological roles 
[12,13]. Vitamin E is a potent antioxidant; its function as a peroxyl radical scavenger that terminates 
chain  reactions  is  well  documented  [14,15].  The  beneficial  effects  of  vitamin  E,  particularly  of  
-tocopherol, include its position and movement within the cellular membrane, its ability to donate 
H atoms,  as  well  as  the  efficiency  of  tocopheroxyl  radical  recycling  by  cytosolic  reductants  
(i.e., Antioxidant network vitamin E–vitamin C–Glutathione (GSH)–thiol redox cycle) [16,17]. In light 
of  these  properties,  the  use  of  antioxidant  compounds  as  counteracting  agents  against  both  the 
oxidative damage induced by OTA through membrane lipid peroxidation and OTA genotoxicity have Toxins 2010, 2                      
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been reported by several authors [18,19]. In vivo, it has been demonstrated that vitamin E decreases 
OTA genotoxicity [20], while our previous in vitro studies indicated that -tocopherol has protective 
activities against OTA, reducing ROS production in established cell lines [18,21]. 
The  primary  aim  of  this  study  was  to  determine  the  toxic  effects  of  OTA  in  primary  porcine 
fibroblast  cell  cultures  by  the  MTT  assay,  LDH  release,  DNA  fragmentation  and  TUNEL  stain. 
Further, we aimed to determine the contribution of -tocopherol in counteracting the cytotoxicity and 
DNA damage induced by OTA in the same in vitro model. 
2. Results and Discussion 
2.1. Cytotoxic effect and LDH release induced by ochratoxin A  
We first investigated the LC50 of OTA after 24 h and 48 h of treatment in ear and embryo porcine 
fibroblasts and found that the LC50 differed between the two cell types. At all incubation times, the 
fibroblasts derived from ear were the most sensitive to OTA cytotoxicity (LC50 = 0.93 g/mL after 
24 h;  LC50 = 0.92 g/mL  after  48 h),  while  fibroblasts  isolated  from  the  embryo  showed  a  time-
dependent sensitivity (LC50 = 4.24 g/mL after 24 h, 2.34 g/mL after 48 h). Previous studies have 
shown different cytotoxic responses to in vitro OTA challenges in different cell lines [18]. Our results 
confirm that the origin of the cells could explain the response to OTA stimuli, as reported by several 
groups [22,23]. To date, most of the studies have been conducted using epithelial cells originated from 
several mammalian species, but only human fibroblasts were used in some studies [19,22]. 
Figure 1 shows the data on LDH release by primary porcine ear and embryo fibroblasts in the 
presence of several concentrations of OTA at 24 and 48 h of incubation. In both cell types, LDH 
release increased significantly (P < 0.01) at OTA concentrations above 2.5 g/mL after 24 and 48 h of 
incubation.  Schwerdt  et  al.  [22],  in  their  studies  on  the  long-term  effects  of  OTA  on  primary 
fibroblasts, indicated that LDH release in the media increased only after five days of exposure to OTA, 
while Russo et al. [19] reported a significant LDH release after 72 h of OTA treatment. However, in 
our study, after only 24 h of incubation, the fibroblast cultures showed considerable LDH release when 
OTA was present at concentrations similar to the doses used by Russo et al. [19], indicating early 
cellular membrane damage. 
Figure 1. Concentration-dependent release of LDH into culture media by primary porcine 
ear and embryo fibroblasts after 24 h (a) and 48 h (b) exposure to OTA concentrations. 
Values are means, with standard errors of the mean represented by vertical bars.  
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2.2. Detection and quantification of DNA damage induced by ochratoxin A  
OTA  was  able  to  induce  DNA  fragmentation  in  both  primary  porcine  fibroblast  cultures,  as 
measured by a diphenylamine assay. After 24 h of incubation, in the absence of OTA (control), 14% 
DNA fragmentation in both primary cultures occurred. A dose-dependent fragmentation in fibroblast 
cultures, due to the exposure to increasing concentrations of OTA, was found (Figure 2). At 0.6 g/mL 
of OTA, the DNA fragmentation percentage of both types of fibroblasts were similar to control levels. 
Exposure to high OTA concentrations (2.5, 5, or 10 g/mL) led to increasing percentages of DNA 
fragmentation  in  the  two  types  of  cells.  At  10  g/mL  of  OTA,  DNA  fragmentation  was  92%  in 
fibroblasts isolated from ear and 66% in embryonic fibroblasts. These results confirm the different 
sensitivities of fibroblasts to OTA-induced cell damage. Russo et al. [19] report that human fibroblast 
cultures  show  DNA  damage  after  72  h  of  OTA  exposure  at  high  concentration.  However,  OTA 
concentrations lower than the dose used by Russo et al. [19] revealed that these damages occurred 
earlier and were present after 24 h of OTA exposure. The different origins of the cells (human vs. 
porcine) could explain the difference in sensitivity. Moreover, as indicated by O’Brien et al. [24], the 
cellular response to OTA toxicity related not only to the amount of the mycotoxin that gained access to 
the cells but also to the individual cell tolerance to OTA load.  
Figure 2. DNA fragmentation in primary fibroblasts 24 h post–OTA stimulation. 
 
Cell death may occur by several mechanisms. It is well known that LDH release is a marker of 
cellular  membrane  damage,  while  DNA  fragmentation  measurements  give  an  indication  of  the 
percentage of fragmented DNA out of the total nuclear DNA of cultured cells. A comparison of DNA 
fragmentation with LDH release after 24 h of OTA exposure is shown in Figure 3. After 24 h exposure 
to  0.6,  5,  or  10  g/mL  OTA  in  both  fibroblast  cultures,  we  observed  that  the  changes  in  DNA 
fragmentation and LDH release were almost proportional. Based on these data, we suggest that the cell 
death process induced by OTA involved both cellular and DNA damage. Gekle et al. [25], showed that 
OTA exposure induces apoptosis and necrosis in the MDCK-C7 and MDCK-C11 cells, respectively, 
as indicated by comparing DNA fragmentation with LDH release.  Toxins 2010, 2                      
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Figure 3. Comparison of DNA fragmentation and LDH release in fibroblasts cultures after 
24 h of exposure  to  0.6, 2.5, 5, or  10  g/mL  OTA. The solid line indicates an equal 
percentage of DNA fragmentation and LDH release. During necrosis, the experimental 
values should be close to this line [25]. In the presence of the selected OTA concentrations, 
in  both  cell  cultures  the  experimental  values  indicated  proportional  changes  in  DNA 
fragmentation and LDH release. 
 
2.3. Detection of DNA damage by TUNEL assay 
In a series of experiments, we examined the effect of OTA exposure on fibroblast cultures using the 
TUNEL assay. Figure 4 shows representative photos of ear fibroblast morphology and nuclear stains in 
cells maintained in culture and exposed to OTA for 24 h. In the absence of OTA, the uniformity of 
monolayers,  the  typical  fibroblast  shape  and  cell-cell  interactions  in  cultures  were  evident  in 
fibroblasts from both sources tested. Only 4% and 6% of nuclei were apoptotic in cultures of primary 
ear and embryonic fibroblasts, respectively. The percentage of dark-brown apoptotic nuclei in primary 
fibroblasts, isolated from ear and embryo, co-incubated for 24 h with 0.6 g/mL of OTA, were 32% 
and 16%, respectively. In both ear and embryo fibroblast cultures after 24 of OTA incubation above 
LC50, monolayers were completely destroyed and cell debris were evident in all the microscopic fields. 
Although studies conducted by several groups [10,22,25] indicate the apoptotic pathway as the 
means by which OTA induces toxicity in vivo and in vitro, the determination of predominant cell death 
pathways depends on several conditions, such as the experimental model, the dose of toxin and the 
duration of the exposure. The mechanisms and morphologies of apoptosis and necrosis are different, 
but there is an overlap between these two processes, in what has been called ―necrosis–apoptosis 
continuum‖ [26]. In fact, it is not simple to distinguish the predominant process, as apoptosis and 
necrosis can occur simultaneously [27]. Understanding the evolution of cell death in cellular models is 
critical. Therefore, once again, it is important not only to consider the concentration and duration of 
toxin exposure and the cell type, but also to employ multiple endpoint assays [24]. 
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Figure 4. Representative photographs of selected fields of TUNEL-stained ear fibroblasts 
are  shown.  The  TUNEL-positive  nuclei,  indicating  apoptotic  cells,  are  stained  brown 
(black arrows), while the vital nuclei are stained violet (haematoxylin). (a) Ear fibroblasts 
in culture for 24 h (no OTA). (b) Ear fibroblasts treated with 0.6 g/mL OTA for 24 h.  
(c) Ear fibroblasts treated with 1.25 g/mL OTA for 24 h. (d) Ear fibroblasts treated with  
1 nM -tocopherol and 0.6 g/mL OTA for 24 h. Bars = 200 m.  
 
2.4. Effect of -tocopherol on ochratoxin A–induced toxicity  
The inhibitory effects of -tocopherol on OTA cytotoxicity were evaluated using several toxicity 
assays: MTT test, LDH release, DNA fragmentation and TUNEL assays. 
Pre-treatment with -tocopherol (1 nM) for 3 h, followed by OTA exposure for 24 h, significantly 
(P < 0.01) reduced the loss of cell viability induced by OTA in both in vitro models, as determined by 
the MTT test: by 17.5% in ear fibroblasts exposed to 0.3 g/mL OTA and by 14.7% in embryonic 
fibroblasts exposed to 0.6 g/mL OTA. Treatment with 1 M of antioxidant solution did not affect 
OTA  toxicity.  After  48  h,  -tocopherol  at  both  concentrations  was  unable  to  counteract  the  
OTA-induced cytotoxicity in either cell type. 
The data on LDH release induced by OTA after 3 h pre-incubation with 1 nM or 1 M -tocopherol 
in fibroblast cultures are shown in Figure 5. At 24 h of incubation, in ear fibroblasts, -tocopherol at 
both  concentrations  significantly  (P  <  0.01)  decreased  LDH  release  when  OTA  was  present  at  
0.3–0.6 g/mL. In embryonic fibroblasts at both concentrations of antioxidant, LDH release in the 
presence of all OTA concentrations used was significantly reduced (P < 0.05) compared to control 
cultures (OTA only). After 48 h of co-incubation with tocopherol and OTA, no difference in LDH 
release in either cell type was detected. These data confirm that the origin of the cells can not only 
explain the response to OTA stimuli, but also the sensitivity to antioxidant response. 
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Figure  5.  Effect  of  -tocopherol  on  OTA-induced  LDH  release  in  primary  porcine 
fibroblasts at 24 h. Values are means, with standard errors of the mean represented by 
vertical bars. (a) Ear fibroblasts. (b) Embryonic fibroblasts. 
 
The  effects  of  3  h  pre-incubation  with  1  nM  or  1  M  -tocopherol  on  OTA-induced  DNA 
fragmentation in primary fibroblasts is shown in Figure 6. Treatment with 1 nM α-tocopherol resulted 
in a significant (P < 0.05) decrease in DNA fragmentation compared with control incubation (OTA 
only). This decrease was 15% in the presence of 5 g/mL of OTA in ear fibroblasts and 16% in the 
presence of 10 g/mL of OTA in embryonic fibroblasts. 
Figure 6. Effect of -tocopherol on OTA-induced DNA fragmentation in primary porcine 
fibroblasts at 24 h. Values are means, with standard errors of the means represented by 
vertical bars. (a) Ear fibroblasts. (b) Embryo fibroblasts. 
 
The effects of -tocopherol pre-treatment on DNA fragmentation induced by OTA were evaluated 
by TUNEL assay. In ear fibroblasts α-tocopherol pre-treatment (1 nM or 1 μM) did not significantly 
reduce the percentage of apoptotic nuclei by 12% and 9%, respectively. A representative photograph 
of ear fibroblasts pre-incubated with -tocopherol and co-incubated with 0.6 g/mL OTA for 24 h is 
shown  in  Figure  4(d).  In  embryonic  fibroblasts,  α-tocopherol  pre-treatment  (1  nM  or  1  μM) 
insignificantly decreased the percentage of apoptotic nuclei in the presence of 0.6 μg/mL OTA by 11% 
and  8%,  respectively.  α-tocopherol  was  not  able  to  reduce  the  damage  to  nuclei  when  OTA 
concentrations were above LC50 (embryonic: 5 g/mL OTA; ear: 1.2 g/mL OTA), since the cells of 
treated monolayers detached, and cellular debris floated in the observed fields (data not shown). Toxins 2010, 2                      
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Taken together, our results indicate that -tocopherol counteracts the toxicity of the mycotoxin 
OTA. In particular, the pre-incubation with -tocopherol reduced LDH release and DNA damage in 
both fibroblast cultures, thereby preserving the integrity of the cells. It is well known that -tocopherol 
is fundamental to cellular defence mechanisms against endogenous and exogenous oxidant agents [15]. 
This compound is a peroxyl radical scavenger that terminates the free radical chain reaction [16], and 
its hydrophobic nature stabilises its position in the phospholipid bilayer. In fact, in the core of the 
cellular  membrane,  as  described  by  Traber  and  Atkinson  [16],  the  antioxidant  characteristics  of  
-tocopherol  are  due  to  its  H  atom  donating  ability,  its  position  and  movements  in  the  cellular 
membrane, and its activity in cytosolic reduction reactions that recycle tocopheroxyl radicals, thus 
preventing lipid peroxidation.  
As demonstrated by Baldi et al. [18], in MDCK and BME-UV1 cell lines, the cytotoxicity and ROS 
production induced by OTA are reduced by antioxidant pre-treatments. In particular, -tocopherol 
significantly  reduces  OTA-induced  ROS  production.  This  inhibition  is  concentration-dependent: 
treatment with a higher concentration (10 mM) results in a significantly greater degree of protection 
against ROS production. OTA causes lipid peroxidation and free radical formation in mammalian 
cells.  The  oxidative  metabolism  sustained  by  enzymes  such  as  cytochrome  P450  enzymes  and 
enzymes with peroxidase activities, is responsible for OTA biotransformation and subsequent ROS 
production [28]. The OTA toxicity reduction is due to the scavenging of lipid hydroperoxil radicals by 
vitamin E. This is due to the increase in the activity of the glutathione peroxidase, which utilizes GSH 
for catalyzing the reduction of hydroperoxides [20]. 
Moreover, in BME-UV1 cells, -tocopherol at two different concentrations (1 nM and 10 M) 
reduces DNA fragmentation [21]. In this study, antioxidant pretreatment resulted in a reduction of 
DNA fragmentation by 2–5% in the presence of 0.6–2.5 g/mL OTA. Schaaf and co-workers [29], in 
their  studies  on  oxidative  damage  and  free  radical  generation  induced  by  OTA,  observed  that  
-tocopherol at micromolar concentrations does not prevent the loss of cell viability in cultured renal 
cells. As described by Azzi [14], the effect of -tocopherol depends on the oxidative environment in 
which it is active. This interaction allows -tocopherol to act as a sensor, monitoring the cellular 
environment through concentration changes and transferring the information from the membrane to the 
nucleus. The effects of - tocopherol on protein kinase C and the other molecular signaling pathways, 
as  suggested  by  Fazzio  et  al.  [30],  could  vary,  considering  the  cell-specific  pathways  of  cellular 
proliferation in which vitamin E can act. 
3. Materials and Methods  
3.1. Chemicals  
Ochratoxin A, racemic -tocopherol, penicillin, streptomycin and 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide  (MTT)  were  purchased  from  Sigma-Aldrich  (St.  Louis  MO,  USA). 
Dulbecco’s  Minimum  Essential  Medium  (DMEM)  and  glutaMax  were  obtained  from  Gibco 
(Invitrogen); and FBS (South America) from Bio Whittaker. Ochratoxin A was dissolved in methanol 
to  obtain  a  stock  solution  of  5000  g/mL.  According  to  the  data  obtained  in  preliminary  studies 
[31,32], racemic -tocopherol was dissolved in absolute ethanol to prepare a stock solution of 10 mM. Toxins 2010, 2                      
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These stock solutions were used for further dilutions in DMEM containing 0.6% FBS to obtain the 
final concentrations of each compound. 
3.2. Cell culture 
In this study, primary porcine fibroblasts isolated from embryo and from ear were used. Fibroblasts 
were grown in monolayers in 75-cm
2 plastic culture flasks (Nunclon, Nunc Denmark) in Dulbecco’s 
Minimum  Essential  Medium  (DMEM)  supplemented  with  1%  glutaMax,  2500  I.U./mL  penicillin,  
2.5  mg/mL  streptomycin  and  10%  FBS.  Primary  fibroblasts  were  cultivated  in  a  humidified 
atmosphere with 5% CO2 at 37 °C  and split 1:4 once a week. In all experiments in this study, we used 
embryonic porcine fibroblasts between passages 5 and 10 and ear between 5 and 8. All experiments 
were conducted in media containing 0.6% serum, the minimum useful concentration to maintain the 
selected in vitro models. 
3.3. Determination of the half-lethal concentration and LDH release induced by ochratoxin A  
Cells were seeded in 96-well culture plates (3000 cells/well, in 200 μL of complete medium) and 
were cultured for 24 h. A dose–response experiment was set up. Fibroblast cultures were exposed to 
increasing concentrations of OTA (0–10 g/mL) for the following 24 or 48 h. 
The effects of OTA treatments on fibroblast viability were determined using the MTT test. Cellular 
viability  was  determined  using  a  colorimetric  assay  based  on  the  production  of  the  chromophore 
formazan  from  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide  (MTT).  Formazan  is 
produced in viable cells by the mitochondrial enzyme succinate dehydrogenase. 
At the end of the incubation, the media were removed, the monolayers were washed with PBS 
twice, 150 μL MTT stock solution (5 mg/mL) in PBS was added to each well, and the plates were 
incubated for 3 h at 37 °C  in a humidified chamber. To dissolve the formazan, 150 μL dimethyl 
sulfoxide was added to each well, after discharging the MTT solution. Absorbance at 540 nm was 
determined on a Biorad 680 microplate reader (Bio-rad, Veenendaal, The Netherlands). 
Cells incubated with culture medium alone, representing 100% viability, were included as negative 
controls in all experiments. 
The percentage cytotoxicity was calculated as follows: 
Percentage cytotoxicity = (1 – mean optical density in presence of OTA/mean optical density of 
negative control) ×  100. From these data the half-lethal concentration (LC50) of OTA for each primary 
cell culture was calculated. 
Cell  membrane  damage  induced  by  OTA  was  detected  by  LDH  release  using  a  CytoTox  96
®  
Non-Radioactive Cytotoxicity Assay (Promega) as instructed by the manufacturer. 
Primary porcine fibroblasts were seeded in 96-well plates at the density as described above and 
cultured  for  24  h.  Afterward,  the  cells  were  exposed  to  OTA  solutions  (concentration  range:  
0–10 g/mL) for 24 or 48 h. At the end of the incubation period the media were removed and cells 
washed with PBS twice. 
LDH is a stable cytosolic enzyme released upon cell lysis. The amount of LDH was measured with 
an enzymatic assay using tetrazolium salts in conjunction with diaphorase. Briefly, after treatments 
supernatants were removed and centrifuged for 5 min at 1500 ×  g at 4 ° C. 50 μL of each supernatant Toxins 2010, 2                      
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was transferred to a 96 well plate. Cells were lysed by adding 15 μL of 9% Triton X-100 solution in 
water per 100 μL of culture medium containing 0.6% of serum, followed by incubation for 1 h at 
37 °C . Cells debris were removed by centrifugation for 5 min at 1500 ×  g at 4 ° C and 50 μL of each 
sample was transferred to 96 well plate. Then, 50 μL of LDH substrate was added to the supernatants 
and cell lysates. After incubation for 30 min at room temperature in the dark, the enzymatic assay was 
stopped  by  adding  50  mL  of  1  M  acetic  acid  and  the  plate  was  read  at  490  nm  using  a 
microplate reader. 
The percentage of LDH release was calculated as the amount of LDH in the supernatant over total 
LDH from both supernatant and cell lysate. 
3.4. Detection and quantification of DNA damage induced by ochratoxin A 
DNA fragmentation was measured with the diphenylamine method as described by Sandau et al. 
[33]. Primary porcine fibroblasts were seeded in 75-cm
2 flasks (density: 0.55 ×  10
5 cells/mL) and 
grown at 37 °C   in  5%  CO2  for 5 days.  At sub-confluence, fibroblasts were incubated with OTA  
(0–10 g/mL) for 24 h. After incubation, the media were removed and centrifuged at 1,800 ×  g for  
20 min to collect the detached cells (fraction S). The fraction S was subsequently lysed in 5 mL of  
ice-cold lysis buffer [10 mM Tris, 1 mM EDTA (pH 8.0), 0.5% Triton X-100] for 30 min at 4 ° C. The 
remaining adherent cells were scraped off the plastic and lysed in 5 mL of ice-cold lysis buffer as well.  
After cell lysis, the intact chromatin (fraction B) was separated from DNA fragments (fraction T) by 
centrifugation for 20 min at 13,000 ×  g. Samples were treated with one volume of 25% trichloroacetic 
acid (TCA), precipitated overnight at 4 °C , and recentrifuged 20 min a 13,000 ×  g at 4 °C , and then the 
supernatants were removed. 
DNA was hydrolysed by adding one volume of 5% TCA to each pellet and heating 15 min at 90 °C  
in a heating block. DNA content was quantitated using the diphenylamine reagent. Afterward, 1600 μL 
of DPA solution (in 10 mL glacial acetic acid: 150 mg diphenylamine, 150 μL H2SO4 and 50 μL 
acetaldehyde 16 mg/mL solution) were added to each fraction and incubated for 4 h at 37 °C  in 
the dark. 
The OD600 of each fraction (S, B, and T) was determined. The percentage of DNA fragmented was 
calculated as the ratio of the DNA content in the supernatant (T) to that in the pellet (B), considering 
also the quantity released by cells undergoing apoptosis and lysis during the experiment. 
Percentage of fragmented DNA = [(S + T)/(S + T + B)] ×  100   
3.5. Detection of DNA damage induced by ochratoxin A by TUNEL (TdT-mediated dUTP nick end 
labeling) assay 
Primary porcine fibroblasts were seeded at a density of 0.4 × 10
5 cells/mL in chamber slides, which 
had two chambers (Nunc Lab-Tek, Nunc, Denmark), which were previously coated with a thin layer of 
poly-L-lysine 0.01% (Sigma) to support cellular adhesion. Cells were cultured for 24 h in complete 
medium. Afterward, the media were removed and the fibroblast monolayers washed twice with PBS. 
Based on results obtained from previous assays, 0.6 g/mL OTA and the appropriate LC50 (embryonic Toxins 2010, 2                      
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LC50:  5  g/mL  OTA;  ear  LC50:  1.2  g/mL  OTA)  were  added  to  each  chamber  slide  for  the  
following 24 h. 
At  the  end  of  the  incubation,  the  media  were  removed  and  the  cells  fixed  with  4% 
paraformaldehyde  at  room  temperature  for  25  min.  The  TUNEL  assay  was  performed  using  the 
DeadEnd Colorimetric Apoptosis Detection kit (Promega, Madison, WI, USA). The monolayers were 
washed twice with PBS and permeabilized by immersing the slides in 0.2% Triton X-100 solution in 
PBS for 5 min at room temperature. After washing with PBS, cells were incubated with biotinylated 
nucleotide  mixture  together  with  terminal  deoxynucleotidyl  transferase  enzyme.  Horseradish 
peroxidase–labeled  streptavidin  (streptavidin  HRP)  was  then  added  to  bind  to  these  biotinylated 
nucleotides,  which  are  detected  using  the  peroxidase  substrate  hydrogen  peroxide  and  the  stable 
chromogen diaminobenzidine (DAB). Afterward, to visualize and estimate the apoptotic and normal 
cells, haematoxylin staining was performed. Images (20X and 40X) were captured under an Olympus 
BX51 microscope. For each experiment, ~500 cells were counted in randomly selected fields, and the 
percent of TUNEL-positive cells was calculated. 
3.6. Determination of the effect of -tocopherol against OTA-induced toxicity 
To evaluate the most suitable concentrations of -tocopherol for interaction experiments with OTA, 
a  dose–response  curve  for  this  compound  was  established  using  serial  concentrations  from  the 
nanomolar to micromolar range (data not shown). Cell culture setup and conditions were as detailed 
above. Primary porcine fibroblasts were cultured with LC50 doses of OTA in the presence or absence 
of -tocopherol (1 nM or 1 M). Cell viability and LDH release after antioxidant treatment were 
assessed as previously described. 
To determine cell viability, primary fibroblasts were first pre-incubated for 3 h with -tocopherol 
and then exposed to increasing concentrations of OTA for 24 or 48 h. Cells were also exposed to 
antioxidant alone or ethanol (the -tocopherol solvent) alone to evaluate any non-specific effects. 
Inhibition of cytotoxicity was determined by MTT, LDH release, DNA fragmentation and TUNEL 
assays  and  calculated  as  the  percentage  inhibition  (percentage  cytotoxicity  OTA–percentage 
cytotoxicity of (OTA + antioxidant)). 
3.7. Statistical analysis 
The data are expressed as means ±  standard errors (SE). At least three replicates at each incubation 
time were performed, and all the experiments were performed twice. Obtained data were analyzed by 
one-way ANOVA (General Linear Models Procedure) [34]; Duncan’s post-hoc multiple range test was 
used, with P ≤ 0.05 considered statistically significant. 
4. Conclusions 
Primary porcine fibroblast cultures offer new in vitro opportunities to study OTA cytotoxicity and 
the role of -tocopherol in counteracting the several types of damage induced by this mycotoxin. OTA 
cytotoxicity developed through several mechanisms of action. The cellular inhibition associated with 
the LDH release and DNA fragmentation induced by OTA showed different sensitivities in the two Toxins 2010, 2                      
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fibroblast cultures. -Tocopherol treatments could reduce the damage induced by OTA at different 
cellular levels. Our results point to the conclusion that the use of -tocopherol offers new strategies to 
reduce OTA cytotoxicity, supporting its defensive role in the cell membrane and its multiple functions 
in cellular metabolism. 
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